文献速递睡眠呼吸障碍

脉搏波幅度下降指数:阻塞性睡眠呼吸暂停心血管风险的生物标志物

Pulse Wave Amplitude Drops Index: A Biomarker of Cardiovascular Risk in Obstructive Sleep Apnea.
PubMed 文献 · Am J Respir Crit Care Med · 2023-01-01

该研究基于三个前瞻性队列(HypnoLaus N=1,941、PLSC N=6,367、ISAACC N=692),探讨脉搏波幅度下降(PWAD)指数作为OSA患者心血管风险生物标志物的价值。结果显示,在OSA患者中,低PWAD指数(反映自主神经和血管反应性差)与心血管事件发生率升高独立相关。

要点

  • 低PWAD指数合并OSA患者心血管事件风险显著高于高PWAD合并OSA者及无OSA者。
  • 在HypnoLaus和PLSC队列中,PWAD指数每增加10次/小时,OSA患者心血管事件风险降低。
  • ISAACC队列中,低PWAD且未治疗的OSA患者心血管事件复发率高于无OSA组。

核心结论

  • 在OSA患者中,低PWAD指数反映自主神经和血管反应性差,与心血管风险升高独立相关。

研究设计与样本

  • 研究基于三个前瞻性队列:HypnoLaus(N=1,941)、PLSC(N=6,367)和ISAACC(N=692)。
  • PWAD指数通过基于脉搏血氧的光体积描记信号得出,定义为睡眠中每小时PWAD(>30%)的次数。
  • 参与者按OSA有无(呼吸暂停低通气指数≥15次/小时或无)及PWAD指数中位数分组,主要结局为复合心血管事件发生率。

主要发现

  • 在HypnoLaus队列中,低PWAD合并OSA组相比高PWAD合并OSA组心血管事件风险HR为2.16(95%CI 1.07-4.34,P=0.031),相比无OSA组HR为2.35(95%CI 1.12-4.93,P=0.024)。
  • 在PLSC队列中,低PWAD合并OSA组相比高PWAD合并OSA组HR为1.36(95%CI 1.13-1.63,P=0.001),相比无OSA组HR为1.44(95%CI 1.06-1.94,P=0.019)。
  • 在ISAACC队列中,低PWAD合并OSA未治疗组相比无OSA组心血管事件复发率HR为2.03(95%CI 1.08-3.81,P=0.028)。
  • 在PLSC和HypnoLaus队列中,PWAD指数每增加10次/小时,仅OSA患者心血管事件风险降低(HR分别为0.85 [95%CI 0.73-0.99,P=0.031]和0.91 [95%CI 0.86-0.96,P<0.001])。
  • 在无OSA组和ISAACC队列中,PWAD指数连续变化与心血管事件的关联不显著。

临床怎么用

  • PWAD指数可作为OSA患者心血管风险分层的新型生物标志物,辅助识别高危患者。
  • 对于低PWAD指数的OSA患者,可能需要更积极的心血管风险评估和干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: It is currently unclear which patients with obstructive sleep apnea (OSA) are at increased cardiovascular risk. Objective: To investigate the value of pulse wave amplitude drops (PWADs), reflecting sympathetic activations and vasoreactivity, as a biomarker of cardiovascular risk in OSA. Methods: PWADs were derived from pulse oximetry-based photoplethysmography signals in three prospective cohorts: HypnoLaus (N = 1,941), the Pays-de-la-Loire Sleep Cohort (PLSC; N = 6,367), and "Impact of Sleep Apnea syndrome in the evolution of Acute Coronary syndrome. Effect of intervention with CPAP" (ISAACC) (N = 692). The PWAD index was the number of PWADs (>30%) per hour during sleep. All participants were divided into subgroups according to the presence or absence of OSA (defined as ⩾15 or more events per hour or <15/h, respectively, on the apnea-hypopnea index) and the median PWAD index. Primary outcome was the incidence of composite cardiovascular events. Measurements and Main Results: Using Cox models adjusted for cardiovascular risk factors (hazard ratio; HR [95% confidence interval]), patients with a low PWAD index and OSA had a higher incidence of cardiovascular events compared with the high-PWAD and OSA group and those without OSA in the HypnoLaus cohort (HR, 2.16 [1.07-4.34], P = 0.031; and 2.35 [1.12-4.93], P = 0.024) and in the PLSC (1.36 [1.13-1.63], P = 0.001; and 1.44 [1.06-1.94], P = 0.019), respectively. In the ISAACC cohort, the low-PWAD and OSA untreated group had a higher cardiovascular event recurrence rate than that of the no-OSA group (2.03 [1.08-3.81], P = 0.028). In the PLSC and HypnoLaus cohorts, every increase of 10 events per hour in the continuous PWAD index was negatively associated with incident cardiovascular events exclusively in patients with OSA (HR, 0.85 [0.73-0.99], P = 0.031; and HR, 0.91 [0.86-0.96], P < 0.001, respectively). This association was not significant in the no-OSA group and the ISAACC cohort. Conclusions: In patients with OSA, a low PWAD index reflecting poor autonomic and vascular reactivity was independently associated with a higher cardiovascular risk.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Solelhac G, Sánchez-de-la-Torre M, Blanchard M, et al. Pulse Wave Amplitude Drops Index: A Biomarker of Cardiovascular Risk in Obstructive Sleep Apnea. Am J Respir Crit Care Med. 2023. PMID: 37017487. doi:10.1164/rccm.202206-1223OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。